Home›Trial›NCT06366750
🔬NCT06366750Phase 2ACTIVE NOT RECRUITING

A Study of Barzolvolimab in Patients With Prurigo Nodularis

Study Summary

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.

Conditions
Prurigo Nodularis
Interventions / Drugs
barzolvolimabMatching Placebo
View on ClinicalTrials.gov ↗
Sponsor
CLDX
Celldex Therapeutics
Immuno-Oncology
C50/100
Study Details
Enrollment140 participants
Primary Completion—
Lead SponsorCelldex Therapeutics
Data Retrieved2026-04-11 04:09:37.490185+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.